Nightingale Health
Building sustainable healthcare
How to utilize our products
For healthcare providers
For insurance
For governments and health systems
For consumer health
For telehealth
For medical research
For research
The gold standard ’omics for the research community.
Latest news
Stock exchange release
Nightingale Health Plc’s listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025
Mar 18, 2025
Stock exchange release
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus
Mar 17, 2025
Stock exchange release
Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US
Mar 17, 2025
Stock exchange release
Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki
Mar 12, 2025
Company releases
Nightingale Health’s half-year report: International expansion continues in Southeast Asia and the United States
Mar 06, 2025
Press releases
Nightingale Health to publish half-year report for July – December 2024 on 6 March 2025
Feb 28, 2025